Perfusion (r)evolution.

"When the current use of Perfusion imaging hasn’t evolved since the 90’s, we deliver to clinical routine 25 years of research, publications & (r)evolutions of Perfusion Imaging."

Discover our solution

Unique Perfusion Imaging (r)evolution. Discover our Complete Solution

Cercare Perfusion uniquely provides maps reflecting oxygen availability, in addition to blood flow and volume.

Deeper Insights.Discover our Complete Solution

Our patented Biomarkers allow a more detailed assessment of tissue pathology and therefore optimized patient management for a variety of indications, such as Stroke, Oncology, Alzheimer, Dementia, Neoplasia, COVID-19…

AI.Discover our Complete Solution

Cercare Perfusion uses AI for the stroke lesion detection module, which segments the hypoperfusion and core regions of acute ischemic stroke.

Unique Maps.Discover our Complete Solution

CTH (Capillary Transit Heterogeneity), OEF ( Oxygen Extraction Fraction), and CMRO2 (Cerebral Rate Of O2): Inspect microvascular conditions to elaborate the final interpretation and match with clinical symptoms.

Change Nothing, Get More.Discover our Complete Solution

Gain time and High-level expertise in perfusion imaging for precise, fast, and reliable care without any change in your workflow.

From the field.

“Cerebrovascular Reserve in Moyamoya Disease: Relation to Cerebral Blood Flow, Capillary Dysfunction, Oxygenation, and Energy Metabolism."
Learn more
Cercare Medical @DGNC
Learn more
Cercare Medical @NCR
Learn more
Cercare Medical @ESOC
Learn more
Cercare Medical @ASNR
Learn more
Cercare Medical @DMEA
Learn more
SFNR 2023 with Cercare Medical!
Learn more
Meet us @ECR 2023!
Learn more
Cercare Medical @ArabHealth 2023!
Learn more
RSNA 2022: New global partnership agreement with Viz.ai!
Learn more
Cercare Perfusion Featured on TV4’s Morning News
Learn more
Cercare Medical Partners with Karolinska University Hospital for Clinical Perfusion Imaging
Learn more
Cercare Medical Partners with Arterys to Provide Its Innovative Perfusion Imaging Solution on Arterys’ Cloud-Based Platform
Learn more
Massachusetts General Hospital to Use CERCARE Perfusion in Neuroradiology Research
Learn more
Cercare Medical Receives FDA Clearance for Its AI-Powered Perfusion Imaging Solution
Learn more
Cercare Perfusion Implemented at Aarhus University Hospital for a Pilot Project
Learn more
Cercare Medical Partners with Blackford
Learn more
Cercare Medical Partners with Wellbeing Software
Learn more
Cercare Perfusion is Now Available on syngo.via OpenApps
Learn more
Meet us at RSNA 2019
Learn more
Cercare Medical Receives a €1,8 Million EU Grant
Learn more
Philips Healthworks Breakthrough Day - Video
Learn more
Cercare Medical transforms the future of healthcare with Medtronic
Learn more
Cercare Medical is Partnering with Siemens Healthineers
Learn more

Users of Cercare Perfusion.

**Patricia L. Musolino, MGH-Harvard Medical School**

Assistant Professor of Neurology

**Tobias Granberg, Karolinska Institutet**
Associate Professor

Webinars.

Ronald Borra

Associate Professor of Nuclear Medicine & Molecular Imaging at University of Groningen

Available now

AI-Driven Decision Support in Ischemic Stroke Assessment

Learn more

Rethinking Perfusion Imaging for Oncology Assessment in Brain
Learn more
Capillary Dysfunction as a Common Disease Mechanism
Learn more
AI-Driven Analysis of Advanced Imaging Biomarkers for In-Depth Brain Tumor Assessment
Learn more
AI-Driven Decision Support in Ischemic Stroke Assessment
Learn more

Papers.

Cercare Perfusion: A Novel Approach to Perfusion Imaging Technology for Oncology Assessment
Learn more
Noninvasive Characterization of Tumor Angiogenesis and Oxygenation in Bevacizumab-treated Recurrent Glioblastoma by Using Dynamic Susceptibility MRI: Secondary Analysis of the European Organization for Research and Treatment of Cancer 26101 Trial.
Learn more
Bayesian modeling of Dynamic Contrast Enhanced MRI data in cerebral glioma patients improves the diagnostic quality of hemodynamic parameter maps
Learn more
Perfusion MRI derived indices of microvascular shunting and flow control correlate with tumor grade and outcome in patients with cerebral glioma
Learn more